Key Takeaways
- Guidance cut, CEO owns it: FY23 constant-currency growth lowered to 2% to 4% as the U.S. Mortgage business deteriorated faster than expected through May and June, pushing the expected bottom out by a quarter.
- Mortgage is the whole story: Mortgage revenue fell 48% YoY and will slide further to a $25M–$26M quarterly run rate in Q2, compressing a normal 4–5 year cycle into two. Ex-Mortgage, the rest of the business is expected to grow 16% to 21%.
- Margins crushed, recovery promised: Operating margin fell to 8.0% (down 417 bps YoY) on revenue decline, restructuring costs, and a lagged cost base. Management expects to exit Q4 at an 11.5%–12.0% run rate via three cost levers.
- Healthcare is the offset that must deliver: Healthcare grew 18.1% YoY and carries a healthy pipeline, but Provider revenue is flattish due to long implementation cycles and inconsistent state-level reimbursement rollbacks.
- What to watch next quarter: Whether Mortgage actually stabilizes at the guided $25M–$26M in Q2, whether Healthcare growth accelerates as promised, and whether the margin recovery levers begin to show in the P&L.
The Mortgage Reset
- Revenue collapse: Mortgage revenue contracted 28% QoQ and 48% YoY, driven by the Market Composite Index falling to its lowest level since 2000 and the refinance index dropping 80% YoY.
- Cycle compressed: A normal 4–5 year Mortgage cycle was compressed to two years on both the way up and the way down by record-low rates followed by the fastest Fed rate actions in 40 years, giving the industry, clients, and Firstsource less time to prepare.
- Bottom shifted out: Management had expected Mortgage to find equilibrium in Q2, but revenue slid through May and June. The bottom is now expected in Q3, with Q2 revenue guided to $25M–$26M.
- Mix shift underway: By end of FY23, Mortgage is expected to be two-thirds servicing and one-third origination, down from roughly 40-60 origination-to-servicing currently. The business will shrink to 13%–15% of total revenue from ~28% in FY22.
- Strategy beyond the trough: Management plans to expand into Home Equity, Home Improvement, and other parts of the Mortgage value chain, and to take Mortgage expertise into consumer lending and adjacent BFS areas.
- Support infrastructure realignment: The support infrastructure built for a $200M+ business is being recalibrated for a business that will be roughly halved, with benefits expected from Q3.
Vipul Khanna: "We were expecting that we will taper off, we will kind of find the new equilibrium from Q2. But towards May and June, we have seen sliding down of revenues."
Guidance & The Ex-Mortgage Story
- FY23 constant-currency growth: Lowered to 2% to 4%, driven entirely by the Mortgage downgrade. Excluding Mortgage and the full-year impact of acquisitions, growth is expected at 16% to 21%.
- Q2 revenue: Overall revenue expected to be sequentially flat as Mortgage decline mutes growth elsewhere. Ex-Mortgage, decent growth is expected in Q2 and the trend is expected to continue.
- Collections trimmed: Growth expectations for H2 have been trimmed because inventory is building up slower than anticipated, contributing about 1% to the guidance revision, though macro indicators still point to a gradual increase in delinquency rates.
- UK exposure managed: The UK represents ~30% of revenue, and GBP depreciation creates a cross-currency headwind on dollar-reported revenue. However, offshore GBP revenue is covered at an average rate of 114 versus the current ~95–96, limiting bottom-line impact.
- FY24 ambition: Management expects to deliver top-quartile BPO industry growth at the reported level consistently once the portfolio is realigned after this year, and feels good about medium-term low-to-mid-teens growth in FY24.
Vipul Khanna: "I am disappointed to speak with you once again about lowering our guidance. This is on me, and I am fully aware that we need to provide better clarity on the growth outlook of our businesses."
Margin: The Damage & The Recovery Plan
- Q1 margin: Operating margin fell to 8.0%, a 417 bps YoY decline, driven by a direct cost base imbalance in the Mortgage business, restructuring costs of ~60 bps, and revenue tail-off in Mortgage mid-quarter.
- Three-lever recovery plan: (1) Direct cost for Mortgage realigned to the new revenue base, well underway; (2) Technical and physical infrastructure recalibrated down, benefits from H2 FY23 and more next year; (3) SG&A normalization as a percentage once the transition effect wears off.
- Q2 improvement: Margin improvement expected to begin in Q2 as restructuring costs taper from ~60 bps to ~35–40 bps and direct cost benefits come through.
- H2 lift: Actions on indirect costs (leadership support, infrastructure, facilities, technology) expected to kick in from Q3 and Q4, lifting margins by about 200 bps from Q3.
- Q4 exit rate: Confident of returning to an 11.5%–12.0% operating margin run rate by Q4 FY23. Full-year operating margin expected at 10.0%–10.5%.
- Accounting tailwind: An amended Ind AS 37 on onerous contracts will positively impact operating margin by 80–90 bps in FY23, with 55%–60% of the $783.4M provision value lowering the P&L charge this year.
- Long-term ambition: From FY24 onwards, management expects to resume improving margins by about 25 bps per year through operational efficiency, a trajectory delivered in the years leading up to FY22.
Vipul Khanna: "I have said in the past that we think we would like to get to a place where every year we can improve our margins by about 25 odd basis points to operational efficiency, etc. We had delivered that in leading up to FY22. This is a year of abrasion."
Healthcare: The Growth Engine Under Construction
- Topline growth: Healthcare segment grew 18.1% YoY (13.3% CC), driven by significant wins over the last four quarters. The company is now focused on executing and scaling those wins.
- Provider drag: Provider revenue was flattish due to long implementation cycles (six to nine months for meaningful revenue recognition) and inconsistent government intervention rollbacks in reimbursement cycles across different states. Management described this as minor timing puts and takes, not secular or structural.
- Sales momentum: The company had its strongest Provider sales quarter in about 10 quarters in Q4 FY22, with pretty much the same trajectory of growth in Q1 FY23. Revenue yield is expected to increase in H2 from these wins.
- Pipeline: The pipeline for large deals from top-tier health plans is healthy, and growth is expected to pick up from Q2 onwards on the health plan side.
- Seasonality: Historical uptick expected in Q3 and Q4 across the health plan business due to the open enrollment period leading up to December.
- Margin compression QoQ: Q4 FY22 Healthcare margin was elevated by one-off items that normalized in Q1 FY23. Per management, roughly 25% of the compression was the prior-year one-off and ~75% was current-year investments and growth costs for new business wins.
- Public Health Emergency: The PHE has been extended until end of calendar year 2022, but management has not assumed any uplift from its unwind in forecasts, expecting a slow unwind through the year.
Collections & Diversification
- Growth trimmed: Collections growth expectations for H2 have been reduced because inventory is building up slower than anticipated, though macro indicators continue to point to a gradual increase in delinquency rates.
- Structural delay: The Collections business did not perform well in recent quarters because pandemic-era cash surpluses delayed the normal counter-cyclical pickup. The buildup is taking time and not following predictable patterns.
- Client signals: Clients are telling the company to be prepared for volume increases, and it is showing up in delinquency data. Sales momentum is expected to remain strong through the year.
- Diversification beyond cards: The company has been diversifying beyond credit cards into BNPL and FinTech payment methods, with very good wins in the last two or three quarters with those FinTechs.
- UK Collections win: Secured a win with a key BFS client in the UK for Collections services, opening the Collection Service line with that client.
- Nearshore demand: Strong demand for the recently opened Mexico nearshore location for Collections.
Portfolio & Balance Sheet
- CMT scaling: CMT grew 0.9% YoY (5.9% CC), with the UK portfolio continuing to perform strongly and the North America CMT portfolio scaling up. One new account was added in the tech segment in North America.
- UK BFS strength: UK BFS is growing strongly, with a reinvigorated go-to-market focus delivering a strong quarter of new offering wins and growth, including a digital transformation deal with a leading FinTech.
- Talent constraints: Both UK and US markets face talent shortages at the frontline level, while there is an uptick in demand for offshore and contact center processes in Mexico, Philippines, and India.
- ARSI integration: The acquisition is integrating well, had lower margins than Firstsource, and is on track to reach parity by end of FY23.
- Debt reduction: Net debt was reduced in Q1 FY23, with all cash flow utilized for that purpose. Some working capital was converted to 2-year and 3-year debt to protect against interest rate increases.
- Inorganic strategy: Management continues to look systematically for adjacent growth areas, but nothing is imminent or planned for now.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| FY23 constant-currency revenue growth | 2% to 4% | FY23 full year |
| Ex-Mortgage and ex-acquisition growth | 16% to 21% | FY23 full year |
| Mortgage quarterly revenue | Decline to $25M–$26M in Q2, bottom out in Q3, gradual pickup from Q4 | Q2 FY23 / Q3 FY23 |
| Mortgage as % of business | 13% to 15% (down from ~28% in FY22) | By end of FY23 |
| Mortgage mix | Two-thirds servicing, one-third origination | By end of FY23 |
| Operating margin exit rate | 11.5% to 12.0% | Q4 FY23 |
| Full-year operating margin | 10.0% to 10.5% | FY23 full year |
| Restructuring cost taper | ~60 bps in Q1 to ~35–40 bps in Q2, tapering down thereafter | Q2 FY23 |
| Indirect cost savings lift to margins | ~200 bps | From Q3 FY23 |
| Accounting change margin benefit | 80–90 bps positive impact | FY23 full year |
| Tax rate | 18% to 20% | FY23 full year |
| Annual margin improvement ambition | ~25 bps per year through operational efficiency | From FY24 onwards |
Key Metrics
| Metric | Q1 FY23 |
|---|---|
| Revenue | ₹1,472.4 cr or $191 mn, degrew 2.7% YoY in constant currency and 0.8% in rupee terms |
| Operating margin | 8.0%, degrew 35% YoY, a decline of 417 bps |
| Profit after tax | ₹85.1 cr or 5.8% of revenue, degrew 36.7% YoY with margin decline of 328 bps |
| EPS | Degrew 36.6% YoY |
| FY23 constant currency revenue growth guidance | 2% to 4%, lowered from prior guidance |
| FY23 ex-Mortgage and ex-acquisition constant currency growth guidance | 16% to 19% |
| FY23 full-year operating margin guidance | 10.0% to 10.5%, includes 80–90 bps benefit from Ind AS 37 amendment |
| Q4 FY23 operating margin target | 11.5% to 12.0% |
| BFS segment revenue growth | Degrew 11.9% YoY, 13.3% in constant currency |
| Healthcare segment revenue growth | Grew 18.1% YoY, 13.3% in constant currency |
| CMT segment revenue growth | Grew 0.9% YoY, 5.9% in constant currency |
| Mortgage business revenue | $32 mn, contracted 28% QoQ and 48% YoY |
| Mortgage business expected Q2 FY23 revenue | $25 mn to $26 mn |
| Mortgage share of total business by end of FY23 | 13% to 15%, down from about 28% in FY22 |
| DSO | 59 days, versus 57 days last quarter |
| Net debt | ₹733.3 cr or $92.9 mn, versus ₹801.3 cr or $105.7 mn as of March 31, 2022 |
| Cash from operations | ₹140.8 cr |
| Free cash flow | ₹123.8 cr, after CAPEX of ₹17 cr |
| Tax rate | 18.8%, expected 18% to 20% for FY23 |